Market Cap 8.10M
Revenue (ttm) 70,000.00
Net Income (ttm) 400,000.00
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 571.43%
Debt to Equity Ratio 0.00
Volume 4,000
Avg Vol 16,970
Day's Range N/A - N/A
Shares Out 996,000.00
Stochastic %K 4%
Beta 0.64
Analysts Sell
Price Target $16.00

Company Profile

PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precance...

Industry: Medical Devices
Sector: Healthcare
Phone: 917 813 1828
Address:
360 Madison Avenue, 25th Floor, New York, United States
BigJuicy
BigJuicy May. 6 at 3:38 AM
$PAVM getting rdy to buy heavily at $5 if she gets there.. this is out of control
0 · Reply
Carter113
Carter113 May. 5 at 5:18 PM
$LUCD $PAVM from DDW this week in Chicago, Guidelines supporting EsoGuard by name. Highest level of evidence!!!
1 · Reply
chuckjackson
chuckjackson May. 5 at 4:43 PM
$PAVM volume has been pathetic. There are no buyers out there. Even the investors who got in with 4.61M shares at $6.50 are stuck. They can't sell without collapsing the stock price. Lishan, we are waiting.
0 · Reply
trout290zzaam
trout290zzaam May. 4 at 12:32 PM
$LUCD $PAVM Are we in a news vacuum?
1 · Reply
BigJuicy
BigJuicy May. 1 at 5:31 AM
$LUCD may 21 or 28? When are we getting our cookie? $PAVM
3 · Reply
chuckjackson
chuckjackson Apr. 30 at 6:04 PM
$PAVM please don't fade this to $6.50
0 · Reply
chuckjackson
chuckjackson Apr. 30 at 6:00 PM
$PAVM @BigJuicy oh shoot. I didn't notice that the S3 offering became effective yesterday. That was accelerated. Normally, the SEC will take about a month. This was declared in a week. So we no longer have a tight float of 1.5M shares. There are now 6.11M+ shares that can be sold on a spike with 4.61M shares that come with a cost basis of $6.50. i just hope they don't slowly fade this to $6.50
0 · Reply
TopCharts
TopCharts Apr. 29 at 3:19 PM
$PAVM continued dilution over the years . How much cash do these guys have ?
1 · Reply
SuperGreenToday
SuperGreenToday Apr. 28 at 10:52 PM
$PAVM Share Price: $8.94 Contract Selected: Jun 18, 2026 $2.5 Calls Buy Zone: $1.90 – $2.34 Target Zone: $3.33 – $4.07 Potential Upside: 66% ROI Time to Expiration: 50 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
dmc4321
dmc4321 Apr. 27 at 8:21 PM
$LUCD & $PAVM It is another LIE. Sorry @oaksapollo post. Drug Companies are valued like other drug companies. Molecular testing companies are alued like other molecular testing companies. @oaksapollo might as well have used Ford Motors as a comparison as it would be as relevant.
0 · Reply
Latest News on PAVM
PAVmed Earnings Call Transcript: Q4 2025

Mar 30, 2026, 8:30 AM EDT - 5 weeks ago

PAVmed Earnings Call Transcript: Q4 2025


PAVmed Announces Reverse Stock Split

Dec 30, 2025, 9:01 AM EST - 4 months ago

PAVmed Announces Reverse Stock Split


PAVmed Earnings Call Transcript: Q3 2025

Nov 13, 2025, 8:30 AM EST - 6 months ago

PAVmed Earnings Call Transcript: Q3 2025


PAVmed Earnings Call Transcript: Q2 2025

Aug 13, 2025, 8:30 AM EDT - 9 months ago

PAVmed Earnings Call Transcript: Q2 2025


PAVmed Earnings Call Transcript: Q1 2025

May 15, 2025, 8:30 AM EDT - 1 year ago

PAVmed Earnings Call Transcript: Q1 2025


PAVmed Earnings Call Transcript: Q4 2024

Mar 25, 2025, 8:30 AM EDT - 1 year ago

PAVmed Earnings Call Transcript: Q4 2024


BigJuicy
BigJuicy May. 6 at 3:38 AM
$PAVM getting rdy to buy heavily at $5 if she gets there.. this is out of control
0 · Reply
Carter113
Carter113 May. 5 at 5:18 PM
$LUCD $PAVM from DDW this week in Chicago, Guidelines supporting EsoGuard by name. Highest level of evidence!!!
1 · Reply
chuckjackson
chuckjackson May. 5 at 4:43 PM
$PAVM volume has been pathetic. There are no buyers out there. Even the investors who got in with 4.61M shares at $6.50 are stuck. They can't sell without collapsing the stock price. Lishan, we are waiting.
0 · Reply
trout290zzaam
trout290zzaam May. 4 at 12:32 PM
$LUCD $PAVM Are we in a news vacuum?
1 · Reply
BigJuicy
BigJuicy May. 1 at 5:31 AM
$LUCD may 21 or 28? When are we getting our cookie? $PAVM
3 · Reply
chuckjackson
chuckjackson Apr. 30 at 6:04 PM
$PAVM please don't fade this to $6.50
0 · Reply
chuckjackson
chuckjackson Apr. 30 at 6:00 PM
$PAVM @BigJuicy oh shoot. I didn't notice that the S3 offering became effective yesterday. That was accelerated. Normally, the SEC will take about a month. This was declared in a week. So we no longer have a tight float of 1.5M shares. There are now 6.11M+ shares that can be sold on a spike with 4.61M shares that come with a cost basis of $6.50. i just hope they don't slowly fade this to $6.50
0 · Reply
TopCharts
TopCharts Apr. 29 at 3:19 PM
$PAVM continued dilution over the years . How much cash do these guys have ?
1 · Reply
SuperGreenToday
SuperGreenToday Apr. 28 at 10:52 PM
$PAVM Share Price: $8.94 Contract Selected: Jun 18, 2026 $2.5 Calls Buy Zone: $1.90 – $2.34 Target Zone: $3.33 – $4.07 Potential Upside: 66% ROI Time to Expiration: 50 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
dmc4321
dmc4321 Apr. 27 at 8:21 PM
$LUCD & $PAVM It is another LIE. Sorry @oaksapollo post. Drug Companies are valued like other drug companies. Molecular testing companies are alued like other molecular testing companies. @oaksapollo might as well have used Ford Motors as a comparison as it would be as relevant.
0 · Reply
dmc4321
dmc4321 Apr. 27 at 8:10 PM
$LUCD & $PAVM It's an @oaksapollo post so its a LIE and this one is up there. Using drug companies to value a molecular testing company is NUTS. But it does show the oaksapollo couldnt find One testing company that makes LUCD undervalued.
0 · Reply
dmc4321
dmc4321 Apr. 27 at 7:55 PM
$LUCD & $PAVM It is an @oaksapollo post so its a LIE but hes getting tired so its a medium on the oaksapollo liar scale. Everybody has bad days. EsoGuard is not a population scale counter measure unless oaksapollo has insight on how the North Koreans are weaponizing esophageal cancer to make it airborn. could be true but maybe NOT
0 · Reply
BigJuicy
BigJuicy Apr. 27 at 7:29 PM
$PAVM nice love when this is down massive $LUCD
1 · Reply
xx007xx
xx007xx Apr. 24 at 9:56 PM
$LUCD $PAVM credible? Anonymous forum? Here’s the two prompts. I didn’t go wrong. It’s exactly what was asked.
2 · Reply
dmc4321
dmc4321 Apr. 24 at 9:50 PM
if you want to be credible then include the prompt as that tells us more than the actual answer in most cases. But if you look at my earlier rant about @oaksapollo lies about $LUCD you will see the PCP issue is the critical factor. The single greatest fault was not asking "PCP's do you want to write scrips or do the test yourself?" I had a 1 on 1 with Dennis where he told me "we studied the Cologuard launch and while it was good they made mistakes". thats a pretty much verbatim quote from 6+ years ago that gave me great comfort as a $PAVM bull at that time as it was at least a year before the $LUCD IPO. I actually posted it on twitter as I thought sharing my due diligence and being told that directly by the CFO / President was a worthwhile insight. If you do the math the non test event EsoGuard volume should be up over 4000% and thats CONSERVATIVELY if PCP's were viewing EsoGuard positively. Its around 15%. so share the prompt and i will show you where you went wrong!
0 · Reply
dmc4321
dmc4321 Apr. 24 at 6:57 AM
$LUCD & $PAVM This is so misleading it has to be responded too. Lishan and Dennis are little PIGGIES that each need their $60K a month salaries to pay for their top 1% lifestyles. Based on theri performance they are unemployable because it has been BOTTOM 1%. The real question is why have they built a company that is WRONG SIZED, not right sized. It is quite simple. If they had followed their competitors like Cyted Health who have lost about $4M a year over the last 5 years funded by raises totalling about $20M before they raised $44M in august 2025 to enter the US market Lishan and Dennis's combined salaries (not including expenses, benefits etc) would be equal to 37.5% of their annual loss. If you were looking to cut costs where would you look? Previse is even worse having raised just $3 M BTW Cyted Health has BOTH sold more commercial tests and has BETTER data then EsoGuard. FACTS
0 · Reply
dmc4321
dmc4321 Apr. 24 at 6:15 AM
$LUCD its an oaksapollo post and we are going with the multi LIE all you can eat buffet today. LUCD has runway till March of 2026. BUT Lishan has never dipped below having 2 Qtr's of cash so that means another raise before the end of October 2026. When EsoGuard is approved there will be a 1 day spike as everyone (meaning big money) knows that LUCD needs to raise between $75M (a MINIMUM) and $107M (the maximum allowed under their current S3 now they used $18M yesterday) If they can raise the whole $107M they will. Why? It would be stupid if they didnt. If Esoguard has a slow sales QTR and they need to raise it will be below $1 so the BIGGEST possible is it. Lishan and Dennis are hungry little PIGGIES that have gorged on LUCD & $PAVM and need the $30K each they get from BOTH. That $60K a month pays for a top 1% lifestyle that they will get no where else as there performance has consitently been BOTTOM 1%. They are unemployable based on their track record at LUCD & PAVM. FACT
0 · Reply
BigJuicy
BigJuicy Apr. 23 at 1:42 PM
$LUCD if it doesn’t come out Thursday this drops until Monday then goes up until Thursday then drops again if the lcd isn’t approved. Will continue to do this until the lcd is approved. $PAVM
0 · Reply
trout290zzaam
trout290zzaam Apr. 23 at 1:04 PM
$LUCD Not trying to downplay this offering, because i also am disgusted by i and the further dilution we have seen with $PAVM, but in all fairness, if you are here for the reasons we are all waiting for, this offering (18M) is nothing.
0 · Reply
Ironbow
Ironbow Apr. 22 at 5:35 PM
$LUCD $PAVM Ignore Dipsh!t Dave: dmc4321 🤣
0 · Reply
PortfolioMgmt23
PortfolioMgmt23 Apr. 22 at 5:26 PM
$PAVM $LUCD Am I the only one thinking that @chuckjackson is sounding more and more like are old pal Dave?
4 · Reply